Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients

201184 citationsJournal Articlebronze Open Access

Authors

Katarina Steen Carlsson · Skåne University Hospital

Ulf Persson · Swedish Institute for Health Economics

Marcus Schmitt‐Egenolf · Umeå University

Abstract

When assessing psoriasis treatments and making decisions about treatment guidelines and resource allocation, EQ-5D, DLQI and PASI provide a useful set of complementary tools, answering to different needs. If EQ-5D is not included in the original trial the second-best option in cost-effectiveness studies is to use mapping between DLQI and EQ-5D.

Topics & Keywords

Psoriasis: Treatment and Pathogenesis Dermatology and Skin Diseases Autoimmune Bullous Skin Diseases

Publication Details

Published in: British Journal of Dermatology

Volume 166, Issue 4, pp. 797-802

DOI: 10.1111/j.1365-2133.2011.10778.x

Field-Weighted Citation Impact: 1.60

Command Palette

Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients

Authors

Abstract

Topics & Keywords

Publication Details